Disclosed herein are milk compositions that comprise protein, lipid, and oligosaccharide components at concentrations that mimic and/or are substantially similar to human breast milk as produced by a lactating female. The milk compositions include one or more milk components produced in vitro and/or ex vivo from cultured mammary cells.

Provided is a composition that may be used for a specific use application, such as a composition for enhancing a breast milk component. A composition containing a bacterium of the genus Bifidobacterium as an active ingredient is described.

A spray-dried composition comprising an enzyme which is a β-galactosidase having transgalactosylating activity and a maltodextrin and/or sodium chloride.

The present invention concerns improving sleep in infants by administering nutrition that is at least partly fermented by lactic acid producing bacteria and comprises non-digestible oligosaccharides.

Provided herein are cultured milk products for use as nutritional supplements. Also provided are live cell constructs for producing the cultured milk products and bioreactors for producing the cultured milk products. Secretory IgA compositions and methods of use are also provided.

The present invention relates to nutritional compositions comprising 2′-Fucosyllactose (2′FL) for use in improving the gastrointestinal barrier. In particular, the present invention relates to improving gastrointestinal barrier in an infant, a young child or children aged above 3 years to 8 years.

This specification relates to preparing a purified human milk oligosaccharide (HMO) from an HMO solution by a process comprising nanofiltration, as well as processes for making foods, dietary supplements, medicines and infant formulas comprising a purified HMO. This specification also relates to purified HMOs and foods, dietary supplements, medicines and infant formulas prepared by processes disclosed in this specification.

A method is for stimulating the growth of bacteria of the Bacteroidetes phylum in the gut microbiota of a mammal. The method includes administering a yeast product as a prebiotic agent to the mammal. The yeast product comprises the walls of yeast cells, such as those of the genera Saccharomyces, Pichia, Candida, Kluyveromyces, Yarrowia and/or Wickehomomyces, or a fraction thereof.

The present invention relates to nutritional compositions comprising 2′-Fucosyllactose (2′FL), Di-fucosyllactose (Di-FL), Lacto-N-tetraose (LNT), Lacto-N-neotetraose (LNnT), 3′-Sialyllactose (3′SL) and 6′-Sialyllactose (6′SL) for use in improving gastrointestinal barrier. In particular, the present invention relates to improving the gastrointestinal barrier in an infant, a young child or children aged above 3 years to 8 years.

Disclosed herein are milk compositions that comprise protein, lipid, and oligosaccharide components at concentrations that mimic and/or are substantially similar to human breast milk as produced by a lactating female. The milk compositions include one or more milk components produced in vitro and/or ex vivo from cultured mammary cells.